Year-round allergy medication is essential for the millions of people in the UK living with perennial allergic rhinitis — a condition caused by indoor triggers such as house dust mites, pet dander, and mould spores that persist throughout all seasons. Unlike hay fever, which peaks during pollen season, perennial allergic rhinitis produces continuous symptoms including nasal congestion, sneezing, itchy eyes, and fatigue that can significantly disrupt sleep, work, and daily life. This guide explains the most effective treatment options available in the UK, how to use them safely over the long term, and how combining medication with practical lifestyle changes can help you achieve lasting symptom control.
Summary: Year-round allergy medication refers to treatments used continuously to manage perennial allergic rhinitis, a condition triggered by indoor allergens such as house dust mites, pet dander, and mould spores that cause persistent nasal and ocular symptoms throughout the year.
- Intranasal corticosteroids (e.g. fluticasone, mometasone) are considered first-line treatment for persistent nasal symptoms and require consistent daily use for one to two weeks before full effect is achieved.
- Second-generation oral antihistamines such as cetirizine, loratadine, and fexofenadine are preferred for long-term use due to their significantly lower sedation risk compared with first-generation options.
- Montelukast carries an MHRA warning regarding neuropsychiatric side effects including anxiety, depression, and behavioural changes; patients should report any such symptoms to their GP promptly.
- Topical nasal decongestants must not be used for more than seven days due to the risk of rebound congestion (rhinitis medicamentosa).
- In children using intranasal corticosteroids long-term, growth should be monitored regularly and the lowest effective dose used, particularly if inhaled corticosteroids are also prescribed.
- Referral to an allergy clinic should be considered for persistent moderate-to-severe symptoms, diagnostic uncertainty, or when allergen immunotherapy is being evaluated.
Table of Contents
- What Causes Year-Round Allergies and When to Seek Treatment
- Types of Medication Used for Persistent Allergic Symptoms
- Antihistamines, Nasal Sprays and Other Long-Term Options
- How to Use Allergy Medication Safely Over Months or Years
- Managing Year-Round Allergies Alongside Lifestyle Changes
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
What Causes Year-Round Allergies and When to Seek Treatment
Year-round allergies, clinically referred to as perennial allergic rhinitis, differ from seasonal hay fever in that symptoms persist throughout the calendar year rather than peaking during specific pollen seasons. The most common triggers include house dust mites, pet dander (particularly from cats and dogs), mould spores, and, less commonly in the UK, cockroach allergens. Unlike seasonal allergies, these triggers are present in the indoor environment continuously, making symptom control an ongoing challenge.
Symptoms typically include a persistently blocked or runny nose, sneezing, itchy or watery eyes, and postnasal drip. Some individuals also experience fatigue, reduced concentration, and disturbed sleep — all of which can significantly affect quality of life. In children, perennial allergic rhinitis may contribute to recurrent ear infections or worsening asthma.
Not sure if this is normal? Chat with one of our pharmacists →
You should consider seeking medical advice if:
-
Symptoms persist for more than a few weeks without an obvious cause
-
Over-the-counter remedies are providing insufficient relief
-
Symptoms are affecting sleep, work, or daily functioning
-
You develop wheeze, chest tightness, or shortness of breath alongside nasal symptoms
Seek prompt medical attention if you experience any of the following, as these may indicate a condition other than allergic rhinitis:
-
Persistent one-sided nasal blockage or discharge
-
Recurrent or unexplained nosebleeds
-
Facial pain or swelling
-
Loss of sense of smell
-
Systemic symptoms such as fever or unexplained weight loss
A GP can confirm the diagnosis through clinical history and, where appropriate, refer for skin prick testing or specific IgE blood tests to identify the responsible allergens. UK guidance from NICE CKS (Rhinitis) and the British Society for Allergy and Clinical Immunology (BSACI) recommends a stepwise approach to managing allergic rhinitis, beginning with allergen avoidance and first-line pharmacotherapy. Referral to an allergy clinic should be considered for persistent moderate-to-severe symptoms despite optimal treatment, diagnostic uncertainty, or when allergen immunotherapy is being considered. Referral to ENT is appropriate where nasal polyps, structural disease, or chronic rhinosinusitis is suspected. Early, accurate diagnosis is important to avoid under-treatment and to identify any associated conditions such as asthma.
Types of Medication Used for Persistent Allergic Symptoms
Managing perennial allergic rhinitis typically requires a combination of medication classes, chosen according to the predominant symptoms and their severity. The principal categories of year-round allergy medication include antihistamines (oral and intranasal), intranasal corticosteroids, decongestants, leukotriene receptor antagonists, ipratropium bromide nasal spray, and, in selected cases, allergen immunotherapy.
Oral antihistamines work by competitively blocking H1 histamine receptors, thereby reducing the inflammatory response triggered by allergen exposure. Second-generation antihistamines — such as cetirizine, loratadine, and fexofenadine — are preferred for long-term use because they are significantly less sedating than first-generation options such as chlorphenamine.
Intranasal antihistamines (e.g., azelastine nasal spray) offer a rapid onset of action and can be used as monotherapy or as an add-on to intranasal corticosteroids for patients with breakthrough symptoms.
Intranasal corticosteroids (INCs), such as fluticasone propionate, mometasone furoate, and beclometasone dipropionate, are considered the most effective single treatment for persistent nasal symptoms. They act locally to reduce mucosal inflammation, oedema, and secretion, with minimal systemic absorption at recommended doses. NICE CKS and BSACI guidance supports their use as first-line treatment when nasal blockage is a predominant symptom.
Leukotriene receptor antagonists, specifically montelukast, may be considered as add-on therapy, particularly in patients with coexisting asthma. The MHRA issued updated guidance in 2019–2020 highlighting the potential for neuropsychiatric side effects with montelukast, including sleep disturbances, anxiety, depression, and mood or behavioural changes. Prescribers are advised to discuss these risks with patients and carers before initiating treatment, and patients should be advised to report any such symptoms to their GP promptly.
Experiencing these side effects? Our pharmacists can help you navigate them →
Ipratropium bromide nasal spray may be considered for patients with troublesome watery rhinorrhoea that is not adequately controlled by other treatments.
Decongestants (topical or oral) should be used only for short-term relief of nasal congestion. Topical decongestants (e.g., xylometazoline) must not be used for more than seven days. Oral decongestants (e.g., pseudoephedrine) carry important cautions and should be avoided in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, or prostatic hypertrophy, and must not be used with monoamine oxidase inhibitors (MAOIs).
For patients with severe, refractory symptoms, referral to a specialist allergy clinic for consideration of allergen immunotherapy may be appropriate. UK-licensed options include sublingual immunotherapy (SLIT) tablets for house dust mite and grass pollen allergy, and subcutaneous immunotherapy (SCIT). These treatments aim to modify the underlying immune response and should be initiated and monitored in a specialist setting, with the first dose administered under supervision.
Antihistamines, Nasal Sprays and Other Long-Term Options
For many people managing year-round allergies, antihistamines and nasal sprays form the backbone of long-term treatment. Understanding how to use these medicines correctly — and what to expect from them — is essential for achieving consistent symptom control.
Second-generation oral antihistamines are generally well tolerated for extended use. Cetirizine (10 mg daily) and loratadine (10 mg daily) are available over the counter and are suitable for most adults and children, depending on age and formulation — always follow the specific product's Summary of Product Characteristics (SmPC) for age-appropriate dosing. Fexofenadine (120 mg daily) is licensed for adults and adolescents aged 12 years and over for allergic rhinitis and has a particularly low sedation profile. Even second-generation antihistamines may cause drowsiness in some individuals; patients should be advised to avoid driving or operating machinery if affected. For persistent symptoms, regular daily use is more effective than taking antihistamines only during acute flares; as-needed use may be sufficient for intermittent allergen exposure.
Intranasal corticosteroid sprays require consistent daily use to achieve their full anti-inflammatory effect, which may take one to two weeks to become fully apparent. Patients should be counselled on correct technique — directing the nozzle away from the nasal septum towards the outer wall of the nostril and sniffing gently — to maximise deposition and minimise the risk of nasal bleeding or septal irritation. If nosebleeds occur, patients should temporarily stop the spray and seek advice. Long-term use at licensed doses is considered safe in adults; systemic absorption is negligible with modern formulations. In children, the lowest effective dose should be used and growth should be monitored with prolonged use, in line with product SmPCs.
Combination intranasal sprays containing both a corticosteroid and an antihistamine — specifically azelastine/fluticasone propionate (available on prescription in the UK) — may offer faster relief than either agent alone and are an option for patients with moderate-to-severe symptoms.
Nasal saline irrigation (e.g., saline rinses or sprays) is a safe, non-pharmacological adjunct that can help reduce nasal symptoms and improve the effectiveness of other treatments.
Sodium cromoglicate eye drops remain a useful adjunct for ocular symptoms. For patients with significant nasal congestion, short courses of topical decongestants (e.g., xylometazoline) may provide temporary relief, but use must be limited to no more than seven days to avoid rebound congestion (rhinitis medicamentosa).
If you suspect you are experiencing a side effect from any allergy medication, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
How to Use Allergy Medication Safely Over Months or Years
Long-term use of any medication requires careful consideration of safety, tolerability, and ongoing clinical need. For year-round allergy medication, the most commonly recommended treatments have well-established safety profiles when used as directed.
Intranasal corticosteroids are the most scrutinised class in this context. At standard licensed doses, systemic effects are not considered clinically significant in adults. However, in children — particularly those also using inhaled corticosteroids for asthma — cumulative steroid exposure should be monitored, the lowest effective dose used, and height (growth) monitored regularly as recommended in product SmPCs. Regular review by a GP or practice nurse is advisable.
Key safety considerations for long-term allergy medication use include:
-
Antihistamines: Avoid first-generation antihistamines (e.g., chlorphenamine) for regular long-term use due to sedation and anticholinergic effects, particularly in older adults. Even second-generation antihistamines may cause drowsiness in some individuals — advise caution with driving or operating machinery if affected
-
Montelukast: Monitor for neuropsychiatric symptoms; patients and carers should report any mood changes, sleep disturbances, anxiety, depression, or behavioural changes to a GP promptly
-
Topical nasal decongestants: Restrict use to short courses of no more than seven days; prolonged use causes dependency and worsening congestion
-
Oral decongestants: Use with caution or avoid in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, or prostatic hypertrophy; do not use with MAOIs; seek pharmacist or GP advice before use
-
Eye drops: Preservative-free formulations are preferable for frequent, long-term use to reduce the risk of ocular surface irritation
Pregnancy and breastfeeding: Many allergy medicines require special consideration during pregnancy or breastfeeding. Patients who are pregnant, planning a pregnancy, or breastfeeding should seek advice from their GP or pharmacist before starting or continuing allergy medication. Some intranasal corticosteroids (e.g., budesonide, fluticasone) are generally considered compatible with pregnancy at recommended doses, but individual clinical assessment is essential.
Patients should have their allergy management reviewed at least annually by a healthcare professional. This review should assess symptom control, medication adherence, side effects, and whether further investigation or specialist referral is warranted. The NHS advises that patients should not simply continue purchasing over-the-counter remedies indefinitely without seeking a formal diagnosis, particularly if symptoms are poorly controlled or worsening.
If you think you are experiencing a side effect from any allergy medicine, please report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.
Managing Year-Round Allergies Alongside Lifestyle Changes
Medication alone is rarely sufficient for optimal management of perennial allergic rhinitis. Integrating practical allergen avoidance strategies and lifestyle modifications may help reduce symptom burden and, in some cases, reduce the amount of medication required, although the clinical benefit of individual measures is variable and often modest. A multi-faceted approach is generally recommended.
For house dust mite allergy, commonly recommended measures include:
-
Encasing mattresses, pillows, and duvets in allergen-impermeable covers
-
Washing bedding weekly at 60°C or above
-
Reducing indoor humidity to below 50% using adequate ventilation or a dehumidifier
-
Removing carpets where possible and using a vacuum cleaner fitted with a HEPA filter
-
Minimising soft furnishings and soft toys in bedrooms
For pet dander allergy, the most effective measure is removing the animal from the home, though this is not always acceptable or feasible. If the pet remains, keeping it out of the bedroom, regular grooming (ideally by a non-allergic person), and using air purifiers with HEPA filtration may help reduce airborne allergen levels, though evidence for symptomatic improvement from air purifiers alone is inconsistent.
Mould allergy management focuses on reducing indoor dampness — ensuring adequate ventilation in bathrooms and kitchens, promptly addressing water leaks, and using extractor fans. In the UK, outdoor mould spore counts typically peak in late summer to autumn, so some individuals may notice worsening symptoms during this period and may benefit from reviewing their medication with a GP.
Nasal saline irrigation is a safe, non-pharmacological measure that can help clear nasal passages and may complement other treatments.
Beyond allergen avoidance, general health measures support overall wellbeing. These include maintaining a balanced diet, regular physical activity, adequate sleep, and avoiding smoking — both active and passive — which is known to worsen allergic airway inflammation. These measures support general health but should not be described as directly modifying the allergic disease process.
Patients with poorly controlled symptoms despite medication and lifestyle measures should be referred to a specialist service. Referral to an allergy clinic is appropriate for consideration of allergen immunotherapy, diagnostic uncertainty, or significant impact on quality of life or asthma control. Referral to ENT is appropriate where nasal polyps, chronic rhinosinusitis, or structural nasal disease is suspected. With the right combination of treatment and environmental management, most people with year-round allergies can achieve good symptom control and a meaningfully improved quality of life.
Frequently Asked Questions
What is the most effective year-round allergy medication for a constantly blocked nose?
Intranasal corticosteroid sprays, such as fluticasone propionate or mometasone furoate, are considered the most effective single treatment for persistent nasal blockage caused by perennial allergic rhinitis. They work by reducing mucosal inflammation locally and need to be used daily for one to two weeks before their full benefit becomes apparent. A GP or pharmacist can advise on the most suitable option and correct technique.
Is it safe to take antihistamines every day for years at a time?
Second-generation antihistamines such as cetirizine, loratadine, and fexofenadine are generally considered safe for extended daily use and are well tolerated by most adults. First-generation antihistamines like chlorphenamine should be avoided for regular long-term use due to sedation and anticholinergic effects, especially in older adults. It is advisable to have your allergy management reviewed by a GP at least annually to ensure treatment remains appropriate.
Can I use year-round allergy medication during pregnancy?
Some allergy medicines, including certain intranasal corticosteroids such as budesonide and fluticasone, are generally considered compatible with pregnancy at recommended doses, but individual clinical assessment is essential. Patients who are pregnant, planning a pregnancy, or breastfeeding should always seek advice from their GP or pharmacist before starting or continuing any allergy medication. Self-treating with over-the-counter remedies without professional guidance is not recommended during pregnancy.
What is the difference between year-round allergy medication and hay fever treatment?
Hay fever (seasonal allergic rhinitis) is triggered by outdoor pollen and typically requires treatment only during specific seasons, whereas year-round allergy medication is used continuously to manage perennial allergic rhinitis caused by indoor allergens such as house dust mites and pet dander. The same classes of medication — antihistamines, intranasal corticosteroids, and eye drops — are used for both conditions, but perennial rhinitis often requires a more consistent, long-term treatment approach. Identifying the specific allergen through skin prick testing or blood tests can help tailor treatment more effectively.
How do I get a prescription for stronger allergy medication if over-the-counter options are not working?
If over-the-counter allergy treatments are not providing adequate relief, you should make an appointment with your GP, who can review your symptoms, confirm the diagnosis, and prescribe stronger or combination treatments such as prescription-strength intranasal corticosteroids or the combined azelastine and fluticasone nasal spray. Your GP can also refer you to an NHS allergy clinic if specialist assessment or allergen immunotherapy is appropriate. It is important not to continue purchasing over-the-counter remedies indefinitely without a formal diagnosis, particularly if symptoms are affecting your sleep, work, or quality of life.
Can montelukast be used as a long-term allergy medication, and is it safe?
Montelukast can be used as an add-on treatment for perennial allergic rhinitis, particularly in patients who also have asthma, but the MHRA issued updated guidance in 2019–2020 highlighting a risk of neuropsychiatric side effects including anxiety, depression, sleep disturbances, and behavioural changes. Prescribers are required to discuss these risks with patients and carers before starting treatment, and any such symptoms should be reported to a GP promptly. Montelukast is not typically a first-line choice for allergic rhinitis alone and should be used under medical supervision.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
